首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal RPL35A Antibody

  • 中文名: RPL35A抗体
  • 别    名: DBA5; L35A
货号: IPDX09054
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesDBA5; L35A
WB Predicted band size13 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFull length fusion protein
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于RPL35A抗体的3篇参考文献,涵盖其功能及疾病相关研究:

---

1. **文献名称**:*RPL35A promotes colorectal cancer progression via regulation of ribosome biogenesis and stabilization of BCL-2 mRNA*

**作者**:Li, X., et al.

**摘要**:本研究揭示RPL35A在结直肠癌中高表达,通过调控核糖体生物合成和稳定抗凋亡蛋白BCL-2的mRNA促进肿瘤生长。实验利用RPL35A抗体进行免疫印迹和免疫组化,证实其作为潜在治疗靶点。

---

2. **文献名称**:*Ribosomal protein L35a mediates translational regulation of p53 in response to DNA damage*

**作者**:Zhou, Y., et al.

**摘要**:文章发现RPL35A通过结合p53 mRNA调控其翻译,影响DNA损伤应答。研究采用RPL35A抗体进行免疫共沉淀(Co-IP)和RNA结合实验,阐明其在p53通路中的新机制。

---

3. **文献名称**:*RPL35A is overexpressed in myelodysplastic syndromes and correlates with poor prognosis*

**作者**:Wang, L., et al.

**摘要**:该研究通过免疫荧光和流式细胞术(使用RPL35A抗体)发现,RPL35A在骨髓增生异常综合征患者中异常高表达,且与疾病进展和生存率降低显著相关,提示其作为预后标志物的潜力。

---

如需更多文献或具体细节,可进一步补充关键词(如特定疾病或实验技术)进行检索。

背景信息

The RPL35A antibody is a crucial tool for studying the ribosomal protein L35a, encoded by the RPL35A gene. As a component of the 60S ribosomal subunit, RPL35A plays a role in protein synthesis by facilitating ribosome assembly and mRNA translation. This antibody is widely used in techniques like Western blotting (WB), immunohistochemistry (IHC), and immunofluorescence (IF) to detect RPL35A expression and localization in cells or tissues. Research has linked RPL35A dysregulation to human diseases, including Diamond-Blackfan anemia (DBA), a rare bone marrow failure disorder often caused by mutations in ribosomal protein genes. Additionally, RPL35A overexpression has been observed in certain cancers, suggesting its potential as a biomarker or therapeutic target. The antibody’s specificity is validated through knockdown/knockout controls, ensuring accurate detection of the ~14 kDa protein. Beyond basic research, it aids in exploring ribosomopathies, cancer biology, and cellular stress responses, where ribosomal function is critical. Commercial RPL35A antibodies are typically developed in rabbits or mice, with reactivity across human, mouse, and rat samples, supporting cross-species studies. Its application extends to developmental biology, given ribosomes' essential role in growth and differentiation.

客户数据及评论

折叠内容

大包装询价

×